首页> 外国专利> Cellular in null which produces the antibody for the lens epithelium cell

Cellular in null which produces the antibody for the lens epithelium cell

机译:空细胞产生晶状体上皮细胞抗体

摘要

Disclosed are monoclonal antibodies against lens epithelial cells and methods of producing them. Continuous cell lines for producing monoclonal antibodies to lens epithelial cells are disclosed. Human lens epithelial antibody producing cells are fused with myeloma cells to provide a fused hybrid, the hybrid is cultured, and antibodies specific to human lens epithelial cells are collected. Proliferation of remnant lens epithelial cells after extracapsular extraction is prevented by instilling the monoclonal antibodies specific to lens epithelial cells into the anterior chamber of the human eye and allowed to interact with the lens epithelial cells. Complement is then instilled into the anterior chamber to cause lysis or other damage to the lens epithelial cells thereby preventing them from multiplying and migrating to cover the surface of the lens capsule left in place. This can be done at the time of extracapsular cataract extraction or later to remove a second cataract caused by proliferation of these cells. There is no damage to other parts of the eye, but only to the remnant lens epithelial cells.
机译:公开了针对晶状体上皮细胞的单克隆抗体及其产生方法。公开了用于产生针对晶状体上皮细胞的单克隆抗体的连续细胞系。将产生人晶状体上皮抗体的细胞与骨髓瘤细胞融合以提供融合的杂交体,培养该杂交体,并收集对人晶状体上皮细胞特异的抗体。通过将特异于晶状体上皮细胞的单克隆抗体滴入人眼的前房并使其与晶状体上皮细胞相互作用,可以防止囊外提取后残留的晶状体上皮细胞的增殖。然后将补体滴入前房,以引起晶状体上皮细胞的溶解或其他损伤,从而防止它们繁殖和迁移以覆盖留在原处的晶状体囊表面。这可以在囊外白内障摘除时或稍后进行以去除由这些细胞增殖引起的第二次白内障时进行。对眼睛的其他部位没有损害,仅对残余的晶状体上皮细胞有损害。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号